Abstract. The efficacy of alpha-adrenolytic treatment with oral phenoxybenzamine chloride (40 mg per day during three to four months) has been assessed both clinically and urodynamically among 249 patients with neurogenic bladder function. The results were significantly better in patients with autonomous (n = 95) than in the ones with automatic (n = 154) bladders (urethral sphincter spasticity and detrusor sphincter dyssynergia dominating the clinical picture in the latter event). A further striking difference was noticed when the data were analysed with regard to the patient's age, a far better therapeutic response being regularly recorded in subjects below age 35, while minimal and inconsistent improvements were observed in the older age group. No major side effects were encountered.
Introduction
WITHIN the last decade the relatively new sub speciality of urodynamics has gained increasing recognition as a largely independent, major branch of urology. National and International Societies of Urodynamics have recently been founded in France, Italy, the United States and Japan. Most journals of urology regularly publish editorials and leading articles on urodynamic investigations. A personal market survey, carried out earlier this year in collaboration with eight European manu facturers of urodynamic equipment revealed an unexpectedly high increase of sales over the past five years. In fact, more and more practitioners feel a need to complete their standard X-ray units with integrated, TV-monitored systems, allowing for rapid diagnostic screening of such commonly encountered functional disorders as urge incontinence, chronic retention of neurogenic etiology, etc.
( Thomas et al., 1975) . This interest in the more functional pathology of the lower urinary tract clearly indicates that investigative urology has entered a new era within the last decade. This development has been made possible in view of the tremendous progress that was achieved in the late sixties in several closely affiliated scientific branches.
Modern technology, with its trend towards miniaturisation of electronic equipment nowadays allows for permanent, non-invasive monitoring of most body functions, with minimal inconvenience and hazards for the patient. The well known story behind the pocket calculator in many ways also applies to the currently designed urodynamic devices. As the market increases, prices are curbed, and equipment formerly reserved for major hospitals only is now available in many a practitioner's office.
Concomitantly our knowledge and understanding of the neuro-physiology of the lower urinary tract have greatly improved. Histochemical studies of the bladder and urethra have led to the identification of specific alpha-and beta adrenergic receptors ( stimulation of the beta receptors on the contrary a relaxation of the smooth muscle fibres. A great many papers have also been published on the potent effect of cholinergic agents and cholinesterase inhibitors in the treatment of the hypotonic bladder and, inversely, of anticholinergic medication in the management of the hyperactive, non-inhibited bladder (Norlen, I977; Sundin & Dahlstroem, 1973; Taira, 1972) . Over the past three years evidence has accumulated indicating that prostaglandins may play a significant and hitherto unrecognized part in a variety of dysuric states.
Drug research is turning out new substances at an ever increasing pace, which intervene as activators, some others as inhibitors of the detrusor, trigonum and striated sphincter. At present, more than thirty such agents are distributed through our hospital pharmacy. In patients having sustained spinal cord trauma, their judicious use offers new possibilities in the conservative management of the neuro genic bladder (Benson et al., I976; Bissada et al., I977). Repeated urodynamic assessments, carried out under standard laboratory conditions, allow us to evaluate a patient's individual response to a given medication and to determine an optimal dose range.
Neuropharmacology and Urodynamics
In the routine assessment of the neurogenic bladder the following three tests have been found particularly useful when combined with cysto-sphincterometry (Hachen, I977) .
(a) Urecholine ® baclofen test
In patients presenting a conus lesion and possibly a neurogenic bladder of the 'mixed' type, the recording of reflex detrusor contractions and of a significant rise in intravesical pressure within I5 minutes after the subcutaneous injection of 2·5 mg of bethanechol chloride is compatible with the diagnosis of an upper motor neurone lesion. In our experience this test yields valuable information in the critical assessment of neurogenic bladders of the mixed type. Urecholine should never be administered repeatedly unless the absence of any infravesical obstacle, be it functional or anatomic, has been ascertained with micturition cysto-urethro graphy.
In patients with detrusor-sphincter dyssynergia, the latter may be markedly increased during treatment with cholinergic agents and occasionally give rise to reflux formation (Diokno and Koppenhoefer, I976) .
In male patients with an upper motor neurone lesion and chronic retention due to excessive sphincter spasticity or detrusor-sphincter dyssynergia, the intra-venous injection of 20 mg of baclofen significantly lowers the maximal urethral pressure. This test has proved reliable in the selection of candidates for sphinc terotomy (Hachen & Krucker, 1977) .
This test is primarily indicated in patients with an insufficient opening of the bladder outlet during micturition Olsson et at., 1977) . If one observes a funnel-shaped widening of the trigonum ( = positive answer) within 10 minutes after the intravenous injection of 10 to 15 mg of phentolamine mesylate (alpha-blocking agent), one may assume that the alpha-receptors at the trigonal level are a direct contributing factor responsible for the chronic retention. Over the past 8 years we have observed that this category of patient generally responds well to long-term oral alpha-adrenolytic treatment with phenoxybenzamine hydro chloride (Krane & Olssen, 1973; Mobley, 1976; Stockamp & Schreiter, 1975) .
Clinical Trial with Phenoxybenzamine
Between March 1970 and February 1979,249 male patients with an initially complete spinal cord lesion participated in a study on the efficacy and tolerance of phenoxybenzamine. One hundred and sixty-two patients were hospitalised, the remaining 87 were followed as outpatients. According to the results obtained during pretrial urodynamic evaluation, the patients were assigned either to a group with automatic (154 cases) or autonomous (95 cases) bladder function (Table I) . In order to facilitate statistical analysis and avoid additional unknowns likely to distort the homogeneity of patient groups, all cases with mixed bladders or partial neurogenic involvement were excluded from the trial.
Since a pilot study had yielded particularly promising results in a group of teenagers, an observation also made by De Vogt and Van Der Sluis (1976) , we carried out a further subdivision according to the patient's age; group A: 15-35 years, and group B: 36-50 years.
In view of the possible hazards of a prolonged alpha-blockade among the elderly and expecting in this age group 'a priori' only a minimal therapeutic res ponse, considering the prevalence of severe fibro-sclerotic changes at the bladder neck, we systematically excluded all patients above age 50 (Boreham et at., 1977; Haubensak et at., 1975) .
Phenoxybenzamine hydrochloride was prescribed for periods ranging from 3 to 4 months, at a dosage of 20 mg 12-hourly (Fig. I) . The efficacy of the alpha adrenolytic medication was evaluated both clinically and urodynamically after approximately 1 month of treatment. (1 5 -3 5 years) In this group we evaluated: -the mean decrease of the post-micturition residual volume expressed in percent of the pretreatment values; -the reduction of the trigonal pressure as calculated from the urethral pressure profiles (Brown & Wickham, 1969; Donker et al., 1972; Ghoneim et al., 1975; Tanagho et al., 1969; Whitfield et al., 1976) ;
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-the attenuation or disappearance of pre-existing autonomous waves; -the changes in bladder capacity (volume increase by � 20 per cent); and -the incidence of subsequent bladder neck resections (failure of conservative treatment).
As indicated in Table II , the 67 patients in the younger age group (A) res ponded by a 43 per cent decrease in the residual volume and a 36 per cent decrease in bladder neck resistance (p < 0'001; Student's t-test). Previously recorded autonomous waves disappeared in 33 per cent of the cases (p < 0'01) and an increase in bladder capacity of at least 20 per cent was observed in 54 per cent of the cases (p < 0'01). Bladder neck resections were carried out later on in 10 per cent of the cases who had not responded sufficiently to phenoxybenzamine. A 19 per cent decrease in residual volume and a 9 per cent drop in bladder neck resistance were both at the limit of statistical significance (p < 0·05). With regard to autonomous waves and bladder capacity, we registered barely a trend towards improvement (p = n.s.).
Over-all assessment indicates that phenoxy benz amine failed to improve micturition in half of the patients assigned to group B. All these cases required endoscopic surgery within 6 months following our clinical trial.
(b) Automatic neurogenic bladder function-(n = 154)
Following the initial state of spinal shock (Tulloch & Rossier, 1977) , the large majority of patients with a complete upper motor neurone lesion develops some degree of detrusor sphincter dyssynergia (Jonas & Tanagho, 1975; Yalla et al., 1977) and spasticity of the striated urethral sphincter (Murdock et al., 1976) . The co-existence of these two factors determines the degree of chronic retention which prevails during the early stage of bladder training. Combined radiocinemato graphic and urodynamic studies indicate that urethral sphincter spasticity is the single major cause responsible for chronic retention (Andersen & Bradley, 1976) . -17 per cent of the cases in group A and 4 per cent only in group B presented a funnel-shaped enlargement of the proximal urethra on video-recorded micturi tion cysto-urethrography (Figs 2a, 2b ).
-A reduction of postmicturition volumes to 75 ml or below was observed in 19 per cent of the cases belonging to the younger (A) and in 5 per cent of the ones in the older age group (B). Statistical analysis reveals that these results are at the limit of significance for the subgroup A, and not significant in the subgroup B. These rather disappointing results are partly compensated by the fact that in four among eleven patients with a massive vesico-renal reflux and marked ureteral dilation (known to exist since 3 to 9 months prior to phenoxybenzamine treatment), this reflux disappeared during alpha-adrenolytic treatment. Similar findings have been reported by Stockamp (1975) . that significant improvement of micturition may be observed in the young patients, particularly in teenagers. Subjects above the age of 50 usually respond poorly to alpha-adrenolytic treatment, since their bladder outlet shows various degrees of fibro-sc1erotic infiltration. In a second patient group comprising 154 cases with an automatic neurogenic bladder, the beneficial effect of phenoxybenzamine (reduction of outlet resistance) was largely masked by severe urethral spasticity and vesico-urethral dyssynergia.
No major side effects were observed during prolonged alpha-blockade. In eight tetraplegics with orthostatic hypotension the dose range had to be maintained initially at 20 mg daily before being gradually increased to a therapeutically active level. Retrograde ejaculation has been reported as being a major complication in patients receiving an alpha-blocker. In patients with complete spinal cord lesions this finding is of lesser relevance, since the mechanism of ejaculation is already altered due to damage of the spinal cord and absence of co-ordinated reflex activity. RESUME La phenoxybenzamine, qui agit de fac;on selective sur les alpha-recepteurs, s'est averee ctre fort utile dans la reeducation des vessies neurogenes du type autonome. L'auteur rapporte son experience dans un groupe de 95 patients traites pendant 3-4 mois ala posologie journaliere de 40 mg. A l'aide d'examens urodynamiques (cysto-sphincterometrie et enregistrement du profil uretral), il a ete possible de demontrer que les meilleurs resultats sont generalement rencontres chez les sujets jeunes, ages de moins de 35 ans. Chez l'individu au-dela de la cinquantaine, l'infiltration fibro-sclereuse au niveau trigonal empcche un relachement efficace de la musculature lisse sous l'effet du traitement alpha-adrenolytique. 
